Who is sponsoring NCT01834729?

NCT01834729 is sponsored by Mayo Clinic.

What condition does NCT01834729 study?

NCT01834729 studies Constipation.

What drugs are being tested in NCT01834729?

Interventions: Alfuzosin, Placebo.

What is the status of NCT01834729?

NCT01834729 is currently COMPLETED.

Last reviewed 2019-01-10 · How we verify

Effect of Stress and a Alpha-1 Antagonist on Anorectal Functions

NCT01834729 Phase 2 COMPLETED Results posted

This study is designed to better understand the effects of effects of stress, relaxation, and a medication alfuzosin on bowel control and emptying in healthy people and patients with bowel problems.

Details

Lead sponsor	Mayo Clinic
Phase	Phase 2
Status	COMPLETED
Enrolment	74
Start date	2013-03
Completion	2017-09-06

Conditions

Constipation

Interventions

Alfuzosin
Placebo

Primary outcomes

Weekly Rate of Spontaneous Bowel Movements at 4 Weeks — 4 weeks
A bowel movement is considered a spontaneous bowel movement (SBM) if no laxative, enema, or suppository was taken in the preceding 24 hours.
Weekly Rate of Complete Spontaneous Bowel Movements at 4 Weeks — 4 weeks
If the subject indicates that the spontaneous bowel movement (SBM) was associated with a sensation of complete bowel emptying, the SBM will be counted as a complete spontaneous bowel movement (CSBM).

Countries

United States